Summary
Exposure to 20 mM KCl elicited a Ca++-dependent release of endogenous NA (noradrenaline) from superfused rat hypothalamic slices. Two consecutive exposures, S1 and S2, respectively, produced NA release of similar magnitude (S2/S1 = 1.01 ± 0.07, n = 5). 5-HT (5-hydroxytryptamine), 10µM, inhibited KC1-evoked NA release by 50%, in the presence but not in the absence of the 5-HT2/5-HT1C receptor antagonist ritanserin. 2-ME-5-HT (2-methy-l5-hydroxytryptamine), a selective 5-HT3 receptor agonist, but not α-ME-5-HT (α-methyl-5-hydroxytryptamine), a 5-HT1-like and 5-HT2 receptor agonist, mimicked the 5-HT response in the presence and in the absence of ritanserin. ICS 205–930 ((3α-tropanyl)1H-indole-carboxylic acid ester), 1 nM, and s(-)zacopride, 3 nM, highly selective 5-HT3 receptor antagonists, inhibited the effects of both agonists. These observations provide direct evidence for a 5-HT-mediated modulation of endogeneous NA release from rat hypothalamus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arias, C., Sitges, M., and Tapia, R. (1984). Stimulation of [3H]y-aminobutyric acid release by calcium chelators in synaptosomes. J. Neurochem. 42: 507–514.
Arnold, E. A., Molinoff, P. B., and Rutledge, C. O. (1977). The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. J. Pharm. Exp. Ther. 202: 544–557.
Barnes, N. M., Costall, B., Ironside, J. W., and Naylor, R. J. (1988). Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride. J. Pharm. Pharmac. 40: 668.
Barnes, J. M., Barnes, N. M., Costall, B., Naylor, R. J., and Tyers, M. B. (1989). 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature (London) 338: 762–763.
Blandina, P., Goldfarb, J., and Green J. P. (1988). Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. Eur. J. Pharm. 155: 349–350.
Blandina, P., Knott, P. J., Leung, L. K. H., and Green J. P. (1989a). Stimulation of the histamine H2 receptor in the rat hypothalamus releases endogenous norepinephrine. J. Pharm. Exp. Ther., 249: 44–51.
Blandina, P., Goldfarb, J., Craddock-Royal, B., and Green, J. P. (1989b). Release of engodenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J. Pharm. Exp. Ther. 251: 803–809.
Blandina, P., Goldfarb, J., Walcott, J., and Green, J. P. (1991). Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J. Pharm. Exp. Ther. 256: 341–347.
Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J., and Turnbull, M. (1980).
Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature (London) 283: 92–94.
Buchheit, K-H., Engel, G., Mutschler, E., and Richardson, B. P. (1985). Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Naunyn Schmiedeberg’s Arch. Pharmac. 329: 36–41.
Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C., and Tyers, M. B. (1988). Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br. J. Pharm. 94: 397–412.
Chesselet, M. F. (1984). Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 12: 347–375.
Cohen, M. L., Bloomquist, W., Gidda, J. S., and Lacefield, W. (1990). LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity. J. Pharm. Exp. Ther. 254: 350–355.
Collu, R., Fraschini, F., Visconti, P., and Martini, L. (1972). Adrenergic and serotoninergic control of growth hormone secretion in adult male rats. Endocrinology 90: 1231.
Conway, S., Richardson, L., Speciale, S., Moherek, R., Mauceri, H., and Krulich, L. (1990). Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat. Endocrinology 126: 1022–1030.
Derkach, V., Surprenant, A., and North, R. A. (1989). 5-HT3 receptors are membrane ion channels. Nature (London) 339: 706–709.
Donatsch, P., Engel, G., Richardson, B. P., and Stadler, P. A. (1984). ICS 205–930: A highly selective and potent antagonist at peripheral neuronal 5-hydroxytryptamine (5-HT) receptors. Br. J. Pharmac. 81: 34P.
Feuerstein, T. J., and Hertting, G. (1988). Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: Evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedeberg’s Arch. Pharmac. 333: 191–197.
Fozard, J. R. (1984). MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedeberg’s Arch. Pharmac. 326: 36–44.
Fozard, J. R., Mobarok Ali, A. T. M., and Nevgrosh, G. (1979). Blockade of serotonin receptors on autonomic neurones by (-)cocaine and some related compounds. Eur. J. Pharmac. 59: 195–210.
Gaddum, J. H., and Picarelli, Z. P. (1957). Two kinds of tryptamine receptors. Br. J. Pharmac. 12: 323–328.
Göthert, M. (1988). Modulation of transmitter release by presynaptic serotonin receptors. In Herting, G., and Spatz, H.-C. (eds). Modulation of synpatic transmission and plasticity in nervous systems, NATO ASI Series, Vol. Hl9 Berlin-Heidelberg: Springer, pp. 55–68.
Gray, J., and Green, A. R. (1987). GABAB-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex. Br. J. Pharm. 91: 517–522.
Herdon, H., Strupish, J., and Nahorski, S. (1985). Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition. Brain Res. 348: 309–320.
Herdon, H., and Nahorski, S. R. (1987). Comparison between radiolabelled and endogeneous dopamine release from rat striatal slices: effects of electrical field stimulation and regulation by Dz autoreceptors. Naunyn-Schmiedeberg’s Arch. Pharm. 335: 238–242.
Hoyer, D. (1988). Molecular pharmacology and biology of 5-HT,c receptors. Trends Pharmacol. Sci. 9: 89–94.
Hoyer, D., Waeber, C., Schoeffter, P., Palacios, J. M., and Dravid A. (1989). 5-HT,c receptor mediated stimulation of inositol phosphate production in pig choroid plexus: A pharmacological characterization. Naunyn Schmiedeberg’s Arch. Pharm. 339: 252–258.
Ismaiel, A. M., Titeler, M., Miller, K. J., Smith, T. S., and Glennon, R. A. (1990). 5-HT, and 5-HT2 binding profiles of serotonergic agents a-methylserotonin and 2-methylserotonin. J. Med. Chem. 33: 755–758.
Ireland, S. J., and Tyers, M. B. (1987). Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br. J. Pharmac. 90: 229–238.
Kilpatrick, G. J., Jones, B. J., and Tyers, M. B. (1987). Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature (London) 330: 746–748.
Jiang, I. H., Ashby Jr., C. R., Kasser, R. J., and Wang, R. Y. (1980). The effect of intraventricular administration of the 5-HT3 receptor against 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res. 513: 156–160.
Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., and Tyers, M. B. (1988). The potential anxiolytic activity of GR38032F, a 5-HT3 receptor antagonist. Br. J. Pharmac. 93: 985–993.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1985). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275.
Miner, W. D., and Sanger, G. J. (1986). Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br. J. Pharmac. 88: 479–499.
Molineaux, S. M., Jesse], T. M., Axel, R., and Julius, D. (1989). 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc. Natl. Acad. Sci. USA 86: 6793–6797.
Okada, M., Mine, K., and Fujiwara, M. (1990). The Na+-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes. J. Pharm. Exp. Ther. 252: 1283–1288.
Pazos, A., and Palacios, J. M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346: 205–230.
Pazos, A., Cortés, R., and Palacios, J. M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346: 231–249.
Pinkus, L. M., Sarbin, N. S., and Gordon, J. C., and Munson Jr., H. R. (1990). Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers. Eur. J. Pharm. 179: 231–235.
Richardson, B. P., Enget, G., Donatsch, P., and Stadler, P. A. (1985). Identification of 5-hydroxytryptamine M-receptor subtypes and their specific blockade by a new class of drugs. Nature (London) 316: 126–131.
Round, A., and Wallis, D. I. (1986). The depolarizing action of 5-hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205–930. Br. J. Pharmac. 88: 485–494.
Sanger, G. J. (1987). Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptor subtypes by BRL 24924: Potential clinical importance of BRL 24924. Br. J. Pharm. 91: 77–87.
Schlicker, E., Classen, K., and Göthert, M. (1984). GABA receptor-mediated inhibition of serotonin release in the rat brain. Naunyn Schmiedeberg’s Arch. Pharm. 326: 99–105.
Schmidt, C. J., and Black, C. K. (1989). The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine. Eur. J. Pharm. 167: 309–310.
Smith, W. L., Sancilio, L. F., Owera-Atepo, J. B., Naylor, R. J., and Lambert, L. (1988). Zacopride: A potent 5-HT3 antagonist. J. Pharm. Pharmacol. 40: 301–302.
Subramanian, N., and Mulder, A. H. (1967). Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. Eur. J. Pharm. 43: 143–152.
Todorovic, S., and Anderson, E. G. (1990). 5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsol root ganglion neurons. Brain Res. 511: 71–79.
Yakel, J. L., and Jackson, M. B. (1988). 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron 1: 615–621.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Blandina, P., Goldfarb, J., Green, J.P. (1991). Stimulation of 5-HT3 Receptors Inhibits Release of Endogenous Noradrenaline from Hypothalamus. In: Fozard, J.R., Saxena, P.R. (eds) Serotonin: Molecular Biology, Receptors and Functional Effects. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7259-1_30
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7259-1_30
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7261-4
Online ISBN: 978-3-0348-7259-1
eBook Packages: Springer Book Archive